2019, Fort Lewis College, Ateras's review: "Order cheap Prednisone no RX - Safe online Prednisone no RX".
The arteries and veins in the placenta fan out and penetrate into the wall of the uterus to interact with the mother’s circulatory system buy cheapest prednisone allergy treatment arizona. This enables the baby to draw oxygen and food from the mother’s system cheap prednisone 10 mg free shipping allergy testing minneapolis, and send waste products to the mother for removal. The mother usually becomes quite elated at this time, as she realises that there really is a baby inside her. The movements become gradually stronger throughout pregnancy, until it is possible to trace the movement of a limb across the belly. Babies vary dramatically in how much they move - some are very active indeed, while others are relatively quiet. During the last couple of weeks of pregnancy the baby does not move as much, as the amount of space available becomes more restricted. This is the earliest that a baby has a reasonable chance of surviving outside the mother, although infants are still at high risk if born before 32 weeks. The trigger for this is not accurately known, but a series of nervous and hormonal stimuli dilates the cervix that guards the opening into the womb, and starts the rhythmic contractions of the womb, which will bring another human being out into the world. Usually the internal foetus is deformed, incapable of independent existence and very small but may appear as a non- cancerous mass that causes symptoms at birth or later in life. This failure of foetus to achieve its full growth potential may be due to problems with the foetus, mother or placenta. Factors due to the mother include high blood pressure (maternal hypertension), german measles (rubella), toxoplasmosis, Herpes infection, cytomegalovirus, cytotoxic medications, irradiation, diabetes, chronic renal disease, malnutrition, anaemia, family history, drug abuse, alcoholism, heavy smoker and high altitude. Factors due to the foetus include congenital, genetic or chromosomal abnormalities, cerebral palsy, foetal infections and twins. The usual factor due to the placenta is abruptio placentae (separation of the placenta from the uterus). It is essential for the basic functioning of the nucleus in cells, and extra amounts may be needed during pregnancy, breast feeding, and in the treatment of anaemia and alcoholism. It is found naturally in liver, dark green leafy vegetables, peanuts, beans, whole grain wheat and yeast. The amount in red blood cells can also be measured (normal range is a level greater than 318 nmol/L or 140 ng/mL), which gives a longer term picture than the normal folic acid level in blood which may be affected by recent changes in diet. Low levels can be due to long-term alcoholism, oral contraceptive use, anticonvulsant medications, malnutrition, sprue (poor food absorption), sickle cell anaemia, cytotoxic drugs (used to treat cancer), pregnancy and food malabsorption syndromes. They can be used not just to help pull out the child, but to turn the head into a more appropriate position if the head is coming out at the wrong angle. Once placed carefully in position, the doctor, in time with the contractions, will apply traction (and sometimes rotation) to deliver the head. The baby may be born with some red marks on its face and head from the forceps, but they disappear after a few weeks. During this time, routine tests and checks are performed, and the anaesthetist will check the heart, lungs and other vital systems. About an hour before an operation, the patient is changed into an easily removable gown and given an injection to dry up the saliva and induce relaxation. While breathing oxygen through a mask a needle is placed in a vein and a medication is injected to induce sleep and relax the muscles (eg. The drugs used last only a short time, and the anaesthesia is maintained by gases that are given through a mask or by a tube down the throat (endotracheal tube). The anaesthetist regularly checks the pulse, blood pressure, breathing and heart during the operation to ensure there is no variation from the normal. When the operation is finished, the anaesthetist turns off the gases and gives another injection to wake up the patient. The first memory after the operation is of the recovery room where the patient stays under the care of specially trained nurses and the anaesthetist until fully awake. Side effects of a general anaesthetic can include a sore throat (from the tube that was placed down the throat), headache, nausea, vomiting and excessive drowsiness (all side effects of the medication). General anaesthetics are now extremely safe, and the risk of dying from the effects of a general anaesthetic are now no greater than one in 250,000. Humans have a gestation period of about 38 weeks (although pregnancy is calculated as lasting 40 weeks from the last menstrual period). The abbreviation G4P2M1 in medical notes would indicate a pregnancy history of a woman in her fourth pregnancy who had delivered two live babies and had one miscarriage (gravida four, parturition two, miscarriage one). Symptoms may be reduced by eating small, frequent meals so that there is never too much food present but always enough to absorb the stomach acid. Antacids can usually be taken safely at most stages of pregnancy, and may be used to relieve more severe symptoms. If a doctor examines the uterus through the vagina with one hand, while the other feels the uterus by pressure on the belly, an empty softened area can be felt between the firmer cervix and the globular uterus in a pregnant woman between the 6th and 10th weeks. It occurs in less than one in ten thousand pregnancies, and is an autoimmune reaction that may be aggravated by oestrogen. Patients develop extremely itchy, fluid filled, scattered small lumps on the body, particularly the belly, sides of the trunk, palms and soles. The prognosis is good and the condition usually does not affect the baby, but it tends to recur in subsequent pregnancies. Labour can be induced in a number of ways, including rupturing the membranes that surround the baby through the vagina, stimulating the cervix, by tablets, vaginal gel (eg. Using these methods, doctors can control the rate of labour quite accurately to ensure that there are no problems for either mother or baby. There is some evidence that labour can be induced in the last week or two of pregnancy by an orgasm after sexual intercourse or by the constant stimulation of the nipples. Iron is used as a medication in tablet, capsule, mixture or injection forms to treat or prevent iron deficiency and some types of anaemia. Pregnant women are at risk of iron deficiency because the developing baby to build muscle and blood cells. In medication, it is not pure iron that is used, but various salts (compounds) of iron such as ferrous gluconate, ferrous phosphate, ferrous sulfate, ferric ammonium citrate, ferric pyrophosphate, ferrous fumarate and iron amino acid chelate. Iron is absorbed from the gut at a set rate, and using higher doses is unlikely to have any clinical effect. Iron should not be used if suffering from haemochromatosis, ulcerative colitis, ileostomy or colostomy, anaemia not due to iron deficiency. Iron supplements interact with many other drugs including tetracycline, penicillamine, antacids, calcium, methyldopa, levodopa, chloramphenicol, cimetidine, thyroxine, phenytoin, cholestyramine and St. This is called a Ker incision and causes fewer long-term problems to the woman than any other form of incision into the uterus as it heals very well. Every few hours you have Branxton-Hicks contractions that can be quite uncomfortable and sometimes wake you at night, but they always fade away. Your back aches, and you are going to the toilet every hour because your bladder has nowhere to expand. Suddenly you notice that you have lost some bloodstained fluid through the vagina, and the contractions are worse than usual.
In elderly institutionalised patients generic prednisone 10 mg online allergy shots nyc, individualised dosing of amantadine buy prednisone 5 mg with mastercard allergy symptoms for cats, based upon a patient’s creatinine clearance, seems to be effective while reducing adverse reactions (Kolbe 2003). Amantadine may cause mydriasis and should therefore not be given to patients with untreated closed-angle glaucoma. Care should be exer- cised when administering amantadine to patients with a history of recurrent ec- zematoid rash, or to patients with psychosis or severe psychoneurosis not controlled by chemotherapeutic agents (Symmetrel 2003). For prophylaxis, amanta- dine should be started as soon as possible after exposure and continued for at least 10 days. Special Dosage: persons with reduced kidney function and elderly persons may need lower doses (or less frequent doses). Reduced clearance in individuals > 60 years and in patients with renal insufficiency: half-life is increased when creatinine clearance is less than 40 ml/min. Comments/Warnings: no well-controlled studies have been done in pregnant women to evaluate the safety of amantadine. Although no informa- tion is available on the effects in infants, the manufacturer recommends that aman- tadine be used cautiously in nursing mothers. Patients receiving amantadine who note central nervous system effects or blurring of vision should be cautioned against driving or working in situations where alert- ness and adequate motor co-ordination are important. Prolonged excretion of amantadine-resistant influ- enza a virus quasi species after cessation of antiviral therapy in an immunocompromised patient. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophy- laxis. Gender and age as factors in the inhibition of renal clearance of amantadine by quinine and quinidine. An amantadine hydrochloride dosing program adjusted for renal function during an influenza outbreak in elderly institutional- ized patients. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. The neuraminidase enzyme is responsible for cleaving sialic acid residues on newly formed virions and plays an essential role in the re- lease and spread of progeny virions. When exposed to oseltamivir, the influenza virions aggregate on the surface of the host cell, thereby limiting the extent of in- fection within the mucosal secretions (McNicholl 2001) and reducing viral infec- tivity. Oseltamivir is indicated in the prophylaxis of influenza and for the treatment of uncomplicated acute illness due to influenza in patients 1 year and older who have been symptomatic for no more than 2 days. H5N1 strains are generally sensitive against oseltamivir, but there are no data on its clinical efficacy. Clinical studies have shown that neuraminidase inhibitors can decrease the duration of influenza-related symptoms if initiated within 48 hours of onset. Clinical efficacy is about 60-70 % and, for treatment started within 48 hours, symptoms such as my- algias, fever, and headache were reduced by approximately 0. Treatment with oseltamivir does not seem to adversely affect the primary in vivo cellular immune responses to influenza virus infection (Burger 2000). Oseltamivir is generally well-tolerated with the only clinically important side effect being mild gastrointestinal upset (Doucette 2001). Recently, the drug has been linked to a number of cases of psychological disorders and two teenage suicides in Japan. However, there is currently no evidence of a causal relationship between oseltamivir intake and suicide. Oseltamivir 195 Structure Oseltamivir is an ethyl ester prodrug which requires ester hydrolysis to be con- verted to the active form, oseltamivir carboxylate [3R,4R,5S]-4-acetamido-5- amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate phosphate. The discovery of oseltamivir was possible through rational drug design utilising available x-ray crystal structures of sialic acid analogues bound to the active site of the influenza virus neuraminidase (Lew 2000). Oseltamivir was developed through modifications to the sialic acid analogue framework (including the addition of a lipophilic side chain) that allow the drug to be used orally (Kim 1998). Pharmacokinetics Following oral administration, oseltamivir is readily absorbed from the gastrointes- tinal tract. After conversion to the active metabolite oseltamivir carboxylate in the liver, it distributes throughout the body, including the upper and lower respiratory tract (Doucette 2001). The active metabolite is detectable in plasma within 30 minutes and reaches maximum concentrations after 3 to 4 hours. Once peak plasma concentrations have been attained, the concentration of the active metabolite declines with an apparent half-life of 6 to 10 hours (He 1999). In patients with renal impairment, metabolite clearance decreases linearly with creatinine clearance, and averages 23 h after oral administration in individuals with a creatinine clear- ance < 30 ml/min (Doucette 2001). A dosage reduction to 75 mg once daily is rec- ommended for patients with a creatinine clearance < 30 ml/min (1. The drug and the active metabolite are excreted by glomerular filtration and active tubular secretion without further metabolism (Hill 2001). Neither compound interacts with cytochrome P450 mixed-function oxidases or glucuronosyltransferases (He 1999). Thus, the potential is low for drug-drug in- teractions, which appear to be limited to those arising from competitive inhibition of excretion by the renal tubular epithelial cell anionic transporter. Probenecid blocks the renal secretion of oseltamivir, more than doubling systemic exposure oseltamivir carboxylate (Hill 2002). This competition is unlikely to be clinically 196 Drug Profiles relevant, but there has been speculation about using probenecid to “stretch” osel- tamivir stocks in situations of pandemic shortage (Butler 2005). The metabolism of oseltamivir is not compromised in hepatically impaired patients and no dose adjustment is required (Snell 2005). In elderly individuals, exposure to the active metabolite at steady state is approxi- mately 25 % higher compared with young individuals; however, no dosage adjust- ment is necessary (He 1999). Young children 1 to 12 years of age clear the active metabolite oseltamivir car- boxylate at a faster rate than older children and adults, resulting in lower exposure. Increasing the dose to 2 mg/kg twice daily resulted in drug exposures comparable to the standard 1 mg/kg twice daily dose used in adults (Oo 2001). Toxicity The most frequent side effects are nausea and vomiting which are generally of a mild to moderate degree and usually occur within the first 2 days of treatment. In many cases, it is not possible to reliably estimate their frequency or establish a cause relationship to oseltamivir exposure:! Aggravation of diabetes Oseltamivir use does not appear to be associated with an increased risk of skin re- actions (Nordstrom 2004); however, anecdotal reports describe isolated skin reac- tions, i. The use of oseltamivir in infants younger than 1 year is not recommended as studies on juvenile rats revealed potential toxicity of oseltamivir for this age group. Moreo- ver, high drug levels were found in the brains of 7-day-old rats which were exposed to a single dose of 1,000 mg/kg oseltamivir phosphate (about 250 times the recom- mended dose in children).
This is signiﬁcant for two rea- oxide) buy generic prednisone 10 mg online allergy forecast georgetown tx, intravenous (opioids) or regional (epidural) are associated sons buy cheap prednisone 20mg on line allergy shots portland oregon. Firstly, the normal signs of hypovolemia may not be seen un- with side effects and risks to both fetus and mother. This extends to include sacral segments (S2-4) during Due to the increasing uterine size, aortocaval compression (obstruc- the second stage. Thus, the principle of epidural analgesia is to ad- tion of the inferior vena cava and aorta) becomes relevant in the minister local anesthetics (with or without opioids) into the third trimester. When the pregnant patient is in the supine posi- epidural space to block the aforementioned spinal segments. The patient remains alert and coopera- lateral tilt, usually achieved with a pillow under the woman’s right tive. In the absence of complications, there are no ill effects on the hip, is an important positioning maneuver. Epidural analgesia can be therapeutic for patients with pre- eclampsia or cardiac disease where a high catecholamine state is detrimental. Finally, the level and intensity of an epidural block can be extended to provide anesthesia for operative delivery (Cae- sarian section). As well as blocking sensory ﬁbres, local anesthetics in the epidural space interrupt transmission along sympathetic and motor neu- rons. The hypotension associated with sympathetic blockade can be minimized by a one litre bolus of crystalloid prior to institution of the block, slow titration of the local anesthetic, the use of lower concentrations of local anesthetic and vigilant guarding against aor- tocaval compression. Whether it also leads to an increased incidence of op- nant patient are those related to the respiratory system. The degree of motor block the risks of aspiration and failed intubation, and the depressant ef- can be minimized by using lower concentrations of local anesthet- fects of anesthetic agents on the fetus, general anesthesia is ics along with opioid adjunct. The use of a local anesthetic infusion avoided (where possible) in the parturient undergoing Caesarian (as opposed to boluses or “top-ups”) may give a more consistent section. Regional anesthesia is the preferred technique and can be level of block, lower total dose of local anesthetic, less motor block provided by administering spinal anesthesia or by extending the and less risk of drug toxicity. These include coagulopathy, hypovolemia, infection, certain cardio- vascular conditions and patient refusal. The second situation where a regional technique may not be appro- priate is in the setting of severe fetal distress. In this setting, gen- eral anesthesia almost always allows the most rapid delivery of the compromised fetus. If the fetal heart rate is very low and the mater- nal airway appears favourable, then general anesthesia will be quickly induced. General anesthesia in the parturient is unique in several respects which reﬂects the many physiologic changes in this patient popula- tion. Other important considerations are the risk of aspiration, rapid desaturation and the need to avoid both neonatal depression and uterine atony. Generally speaking, no opioids are administered until delivery of the infant in order to avoid unnecessary neonatal depression. The patient is maintained on a 50% mixture of nitrous oxide and oxygen, and a low dose of volatile agent. The vola- tile anesthetics, in higher doses, can decrease uterine tone, which can lead to increased blood loss. The parturient must be extubated when fully awake so that intact laryngeal re- ﬂexes will protect against aspiration. Post-operative pain management in the post-Caesarian section patient is usually straightforward as the lower abdominal incision is relatively well-tolerated. In the instance where intrathecal morphine was administered to the patient undergoing spinal anesthesia, up to 24 hours of pain relief can be achieved. This means that the “snifﬁng position” is often best achieved with the head in the neutral position, The pediatric airway is relatively more prone to without the use of a pillow. Infants are obli- tongue may hinder visualization of the larynx or gate nose breathers and the nares are small and contribute to upper airway obstruction under an- easily obstructed by edema or mucous. The narrowest part of the pediatric air- tially life-threatening phenomenon can result 88 from non-speciﬁc stimuli as well as from direct irrita- Table 19 Oxygen reserve, delivery and consumption tion of the vocal cords by blood or secretions. It is common practice, therefore, Firstly, the immature kidney is unable to handle an ex- to pre-treat infants and young children with atropine cessive sodium load. Bradycardia in gen stores may be insufﬁcient to maintain normal se- the pediatric patient must always be assumed to be a rum glucose during a more prolonged period of fast- result of hypoxemia until proven otherwise. This becomes term neonate 80 important when calculating estimated blood loss as a percentage of the estimated blood volume as is done to infant 75 guide to transfusion therapy. Because of its glucose and sodium adult 60 - 70 concentrations, 2/3 D5W-1/3 N/S is appropriate for maintenance ﬂuid administration in adults and chil- dren. In the operating room, we routinely administer Gastrointestinal N/S or R/L for maintenance because it is the crystal- Children, generally speaking, present a lower risk of re- loid of choice for replacing blood volume and third gurgitation and aspiration than adult patients. As well, space losses, which make up the bulk of the ﬂuid needs they will become dehydrated more readily during a pe- in the intra-operative period. For 90 example, it is common practice to allow clear ﬂuids to the child with this technique although the parents, from 2-4-hours pre-operatively in children under 12 for the most part, seem to prefer it. However, for a strug- operatively, breast milk being more readily digestible gling child, a mask induction may be more traumatic than formula. By 6 months to a year of age, infants become sufﬁ- ciently aware of their surroundings to feel anxiety in the immediate pre-operative period. There are many different ap- proaches to minimizing this anxiety which must be in- dividualized according to the needs of the patient, her parents and the anesthesiologist. Unfortunately the administration of a pre- medication (even orally) can be distressing for these pa- tients. In many centers a parent is al- lowed in the operating room for induction to avoid separation anxiety for the child. The anesthesiologist’s involve- practice is, anesthesiologists also have many op- ment in the care of the trauma victim does not 1. Anesthesia Care in Remote portunities to expand their practice outside of this end in the emergency room. The ensuing discussion will look more arrive in the operating room urgently, where resus- closely some these challenging roles. Anesthesiologists may provide conventional anes- thetic services in locations remote from the operat- Many anesthesiologists spend a proportion of ing room, such as radiology, burn center, endo- their clinical time working in the intensive care set- scopy unit, lithotripsy unit, electrophysiology lab, ting. The anesthesiologist monitoring, ventilatory care, pharmacologic sup- is often requested to monitor and sedate patients port and acute pain management, critical care in order to render interventional procedures safer medicine is a natural extension of the anesthesiolo- and more palatable to the patient. Many anesthesi- sia outside the operating room poses unique prob- ologists pursue specialty training in critical care lems for the anesthesiologist and certain risks for after their residency training. These interventions are inten- citates the patient, establishes the extent of injury sive and brief; they require constant and ongoing and carries out appropriate investigations. Typically, the ap- proach to chronic pain is multidisciplinary in that pa- tients are assessed by a social worker, psychologist or psychiatrist, orthopedic surgeon and physiotherapist. Most often, these very complicated patients are re- ferred to the clinic after seeing many other physicians.
Results were consistent across trials buy prednisone 5 mg allergy vs sinus infection, but effects were statistically and clinically nonsignificant quality prednisone 40 mg allergy symptoms back pain, that is, imprecise. The evidence was insufficient to support the use of one treatment over the other for this outcome. Trial size ranged from 101 to 893 patients randomized to treatment groups of interest. In all five trials, the nasal antihistamine was azelastine, and the intranasal corticosteroid was fluticasone propionate. Three 115 trials from the same article used a newly approved combination product comprising both 117, 121 drugs, and two trials used a separate nasal inhaler for each drug in the combination. Of two 117, 121 121 trials that reported the proportions of other races, one included approximately 15 percent Hispanic patients. Individual nasal symptoms (congestion, rhinorrhea, sneezing, and itching) and eye symptoms (itching, tearing, and redness) were rated on a scale from 0 (no symptoms) to 3 (severe symptoms). Morning and evening scores were summed to give a maximum score of 6 for each individual symptom. These results are based on trials using one of eight intranasal corticosteroids (12. As shown in these tables and noted above, several trials reported on each outcome. Four trials (85 percent of patients reporting this outcome) were included in meta- analyses for each nasal outcome. Variance estimates necessary for pooling were not reported by 117 Hampel (2010), preventing inclusion of this trial in the meta-analyses. All five trials showed statistically significant improvements in congestion with combination therapy compared to nasal antihistamine monotherapy. For the outcome of congestion, the risk of bias was rated as low based on the quality of the 115, 121 trials. Statistical heterogeneity of a meta-analysis of four trials was low, and the pooled 117 effect was consistent with the effect reported in the one trial not included in the meta-analysis. The body of evidence supporting a conclusion of equivalence of combination therapy and nasal antihistamine for this outcome was therefore considered precise. All five trials showed greater improvement in rhinorrhea with combination therapy than with 115, 117, 121 117 nasal antihistamine monotherapy. In four trials, including Hampel (2010) whose results were not pooled, treatment effects were statistically significant and ranged from 0. For the outcome of rhinorrhea, the risk of bias was rated as low based on the quality of the 115, 121 trials. Statistical heterogeneity of a meta-analysis of four trials was low, and the pooled 117 effect was consistent with the effect reported in the one trial not included in the meta-analysis. The body of evidence supporting a conclusion of equivalence of combination therapy and nasal antihistamine for this outcome was therefore considered precise. All five trials showed greater improvement in sneezing with combination therapy than with 117 nasal antihistamine monotherapy. In four trials, including Hampel (2010), treatment effects were statistically significant and ranged from 0. For the outcome of sneezing, the risk of bias was rated as low based on the quality of the 115, 121 trials. Statistical heterogeneity of a meta-analysis of four trials was low, and the pooled 117 effect was consistent with the effect reported in the one trial not included in the meta-analysis. The body of evidence supporting a conclusion of equivalence of combination therapy and nasal antihistamine for this outcome was therefore considered precise. In three trials, including Hampel (2010), treatment effects were statistically significant and ranged from 0. Statistical heterogeneity 2 was low to moderate (I =34%) but not statistically significant (p=0. For the outcome of nasal itch, the risk of bias was rated as low based on the quality of the 115, 121 trials. Statistical heterogeneity of a meta-analysis of four trials was low to moderate, and 117 the pooled effect was consistent with the effect reported in the one trial not included in the meta-analysis. The body of evidence supporting a conclusion of equivalence of combination therapy and nasal antihistamine for this outcome was therefore considered precise. Statistical 115, 121 heterogeneity of a meta-analysis of four trials was low, and the pooled effect was 117 consistent with the effect reported in the one trial not included in the meta-analysis. The body of evidence supporting a conclusion of equivalence of combination therapy and nasal antihistamine for this outcome was therefore considered precise. The pooled effect from a meta-analysis of three trials (85 percent 117 of patients reporting this outcome; Hampel  excluded) was 0. Statistical 115 heterogeneity of a meta-analysis of three trials was low, and the pooled effect was consistent 117 with the effect reported in the one trial not included in the meta-analysis. The body of evidence supporting a conclusion of equivalence of combination therapy and nasal antihistamine for this outcome was therefore considered precise. Congestion at 2 weeks: meta-analysis of 4 trials–combination intranasal corticosteroid plus nasal antihistamine versus nasal antihistamine 139 Figure 28. Rhinorrhea at 2 weeks: meta-analysis of 4 trials–combination intranasal corticosteroid plus nasal antihistamine versus nasal antihistamine Figure 29. Sneezing at 2 weeks: meta-analysis of 4 trials–combination intranasal corticosteroid plus nasal antihistamine versus nasal antihistamine 140 Figure 30. Nasal itch at 2 weeks: meta-analysis of 4 trials–combination intranasal corticosteroid plus nasal antihistamine versus nasal antihistamine Figure 31. Total nasal symptom score at 2 weeks: meta-analysis of 4 trials–combination intranasal corticosteroid plus nasal antihistamine versus nasal antihistamine 141 Table 53. Total ocular symptom score at 2 weeks: meta-analysis of 4 trials–combination intranasal corticosteroid plus nasal antihistamine versus nasal antihistamine 142 Table 54. The larger trial (n=459; 75 percent of patients 121 reporting this outcome) showed a treatment effect of 0. For the outcome of quality of life, the risk of bias was rated as low based on the quality of the trials. Evidence to support the use of one treatment over the other for this outcome is insufficient. Trial size ranged from 398 to 744 patients randomized to treatment groups of 102, 104-106 interest. Oral selective antihistamines studied were desloratadine in four trials and 107 103 101 fexofenadine, cetirizine, and loratadine in one trial each. Most patients were female (50 percent to 70 percent), and most were white (80 percent to 87 percent). Two trials also assessed rhinorrhea, 103 101-106 sneezing, and eye symptoms, and one assessed nasal itch. In six trials, patients rated 101 symptom severity on 0 (no symptoms) to 3 (severe symptoms) scale.